Philip Asherson

Factor analysis of schizophrenic symptoms using the OPCRIT checklist.

Factor analysis was performed on OPCRIT checklist psychotic symptoms rated on 102 patients with DSM-III-R schizophrenia. An initial three-factor solution produced positive, negative, and disorganisation factors. However, application of the scree test suggested five substantive factors, with the positive factor dividing into three factors characterised, respectively, by paranoid symptoms, first rank delusions and first rank hallucinations.

ADHD in adults : characterization, diagnosis, and treatment

Preface 1. The course and persistence of ADHD throughout the life-cycle J. Biederman and J. Buitelaar 2. The prevalence and correlates of adult ADHD R. Kessler, J. Buitelaar, Lenard Russell Barkley, J. Biederman, C. Conners, Larry Greenhill, David Shaw and T. Spencer 3. Gender issues in adult ADHD P. Quinn 4. The consequences of ADHD in adulthood: educational, vocational and relational impairments T. Spencer 5. Neurobiology of ADHD J. Krause, Klaus-Henning Krause and Martin Ohlmeier 6. Quantitative and molecular genetic studies of adult ADHD P. Asherson, S. Faraone and F. Levy 7. Structural and functional MRI findings in adults with ADHD Y. Paloyelis 8. Evoked response potentials in adults with ADHD G. McLoughlin 9. Positron Emission Tomography findings in adults with ADHD M. Mehta 10. Diagnosing ADHD in adults L. Adler and David Shaw 11. Neurocognitive characteristics of adults with ADHD J. Dowson and Andrew Blackwell 12. Adult ADHD and mood disorders T. Brown 13. Adult ADHD and anxiety disorders M. Weiss 14. Adult ADHD and substance use disorders T. Wilens 15. Adult ADHD and organic brain disorders A. Niemela and H. Niederhofer 16. Autism spectrum disorders overlap ADHD in adults C. Gillberg 17. Adult ADHD and learning disorders K. Xenitidis 18. Adult ADHD and personality disorders F. van Dijk and Henrik Anckarsater 19. Psychostimulants for adult ADHD T. Spencer and J. Biederman 20. The use of non-stimulant drugs in the treatment of adult ADHD W. Verbeeck 21. Medication management in adult ADHD S. Kooij 22. Abuse potential of stimulant drugs used to treat ADHD S. H. Kollins 23. Psycho-education for adults with ADHD: impressions from the field R. Bruggeman and A. van Lammeren 24. Coaching of adults with ADHD D. Ryffel 25. Clinical applications of research on the psychosocial treatment of adult ADHD M. McDermott 26. EEG biofeedback for adult ADHD Y. Ginsberg 27. Alternative and complementary treatments for ADHD A. Arnold and S. Spetie Appendices Index.

ADHD in Adults: Index

Preface 1. The course and persistence of ADHD throughout the life-cycle J. Biederman and J. Buitelaar 2. The prevalence and correlates of adult ADHD R. Kessler, J. Buitelaar, Lenard Russell Barkley, J. Biederman, C. Conners, Larry Greenhill, David Shaw and T. Spencer 3. Gender issues in adult ADHD P. Quinn 4. The consequences of ADHD in adulthood: educational, vocational and relational impairments T. Spencer 5. Neurobiology of ADHD J. Krause, Klaus-Henning Krause and Martin Ohlmeier 6. Quantitative and molecular genetic studies of adult ADHD P. Asherson, S. Faraone and F. Levy 7. Structural and functional MRI findings in adults with ADHD Y. Paloyelis 8. Evoked response potentials in adults with ADHD G. McLoughlin 9. Positron Emission Tomography findings in adults with ADHD M. Mehta 10. Diagnosing ADHD in adults L. Adler and David Shaw 11. Neurocognitive characteristics of adults with ADHD J. Dowson and Andrew Blackwell 12. Adult ADHD and mood disorders T. Brown 13. Adult ADHD and anxiety disorders M. Weiss 14. Adult ADHD and substance use disorders T. Wilens 15. Adult ADHD and organic brain disorders A. Niemela and H. Niederhofer 16. Autism spectrum disorders overlap ADHD in adults C. Gillberg 17. Adult ADHD and learning disorders K. Xenitidis 18. Adult ADHD and personality disorders F. van Dijk and Henrik Anckarsater 19. Psychostimulants for adult ADHD T. Spencer and J. Biederman 20. The use of non-stimulant drugs in the treatment of adult ADHD W. Verbeeck 21. Medication management in adult ADHD S. Kooij 22. Abuse potential of stimulant drugs used to treat ADHD S. H. Kollins 23. Psycho-education for adults with ADHD: impressions from the field R. Bruggeman and A. van Lammeren 24. Coaching of adults with ADHD D. Ryffel 25. Clinical applications of research on the psychosocial treatment of adult ADHD M. McDermott 26. EEG biofeedback for adult ADHD Y. Ginsberg 27. Alternative and complementary treatments for ADHD A. Arnold and S. Spetie Appendices Index.

ADHD in Adults: List of contributors

Preface 1. The course and persistence of ADHD throughout the life-cycle J. Biederman and J. Buitelaar 2. The prevalence and correlates of adult ADHD R. Kessler, J. Buitelaar, Lenard Russell Barkley, J. Biederman, C. Conners, Larry Greenhill, David Shaw and T. Spencer 3. Gender issues in adult ADHD P. Quinn 4. The consequences of ADHD in adulthood: educational, vocational and relational impairments T. Spencer 5. Neurobiology of ADHD J. Krause, Klaus-Henning Krause and Martin Ohlmeier 6. Quantitative and molecular genetic studies of adult ADHD P. Asherson, S. Faraone and F. Levy 7. Structural and functional MRI findings in adults with ADHD Y. Paloyelis 8. Evoked response potentials in adults with ADHD G. McLoughlin 9. Positron Emission Tomography findings in adults with ADHD M. Mehta 10. Diagnosing ADHD in adults L. Adler and David Shaw 11. Neurocognitive characteristics of adults with ADHD J. Dowson and Andrew Blackwell 12. Adult ADHD and mood disorders T. Brown 13. Adult ADHD and anxiety disorders M. Weiss 14. Adult ADHD and substance use disorders T. Wilens 15. Adult ADHD and organic brain disorders A. Niemela and H. Niederhofer 16. Autism spectrum disorders overlap ADHD in adults C. Gillberg 17. Adult ADHD and learning disorders K. Xenitidis 18. Adult ADHD and personality disorders F. van Dijk and Henrik Anckarsater 19. Psychostimulants for adult ADHD T. Spencer and J. Biederman 20. The use of non-stimulant drugs in the treatment of adult ADHD W. Verbeeck 21. Medication management in adult ADHD S. Kooij 22. Abuse potential of stimulant drugs used to treat ADHD S. H. Kollins 23. Psycho-education for adults with ADHD: impressions from the field R. Bruggeman and A. van Lammeren 24. Coaching of adults with ADHD D. Ryffel 25. Clinical applications of research on the psychosocial treatment of adult ADHD M. McDermott 26. EEG biofeedback for adult ADHD Y. Ginsberg 27. Alternative and complementary treatments for ADHD A. Arnold and S. Spetie Appendices Index.

ADHD in Adults: Frontmatter

Preface 1. The course and persistence of ADHD throughout the life-cycle J. Biederman and J. Buitelaar 2. The prevalence and correlates of adult ADHD R. Kessler, J. Buitelaar, Lenard Russell Barkley, J. Biederman, C. Conners, Larry Greenhill, David Shaw and T. Spencer 3. Gender issues in adult ADHD P. Quinn 4. The consequences of ADHD in adulthood: educational, vocational and relational impairments T. Spencer 5. Neurobiology of ADHD J. Krause, Klaus-Henning Krause and Martin Ohlmeier 6. Quantitative and molecular genetic studies of adult ADHD P. Asherson, S. Faraone and F. Levy 7. Structural and functional MRI findings in adults with ADHD Y. Paloyelis 8. Evoked response potentials in adults with ADHD G. McLoughlin 9. Positron Emission Tomography findings in adults with ADHD M. Mehta 10. Diagnosing ADHD in adults L. Adler and David Shaw 11. Neurocognitive characteristics of adults with ADHD J. Dowson and Andrew Blackwell 12. Adult ADHD and mood disorders T. Brown 13. Adult ADHD and anxiety disorders M. Weiss 14. Adult ADHD and substance use disorders T. Wilens 15. Adult ADHD and organic brain disorders A. Niemela and H. Niederhofer 16. Autism spectrum disorders overlap ADHD in adults C. Gillberg 17. Adult ADHD and learning disorders K. Xenitidis 18. Adult ADHD and personality disorders F. van Dijk and Henrik Anckarsater 19. Psychostimulants for adult ADHD T. Spencer and J. Biederman 20. The use of non-stimulant drugs in the treatment of adult ADHD W. Verbeeck 21. Medication management in adult ADHD S. Kooij 22. Abuse potential of stimulant drugs used to treat ADHD S. H. Kollins 23. Psycho-education for adults with ADHD: impressions from the field R. Bruggeman and A. van Lammeren 24. Coaching of adults with ADHD D. Ryffel 25. Clinical applications of research on the psychosocial treatment of adult ADHD M. McDermott 26. EEG biofeedback for adult ADHD Y. Ginsberg 27. Alternative and complementary treatments for ADHD A. Arnold and S. Spetie Appendices Index.

ADHD in Adults: Contents

Preface 1. The course and persistence of ADHD throughout the life-cycle J. Biederman and J. Buitelaar 2. The prevalence and correlates of adult ADHD R. Kessler, J. Buitelaar, Lenard Russell Barkley, J. Biederman, C. Conners, Larry Greenhill, David Shaw and T. Spencer 3. Gender issues in adult ADHD P. Quinn 4. The consequences of ADHD in adulthood: educational, vocational and relational impairments T. Spencer 5. Neurobiology of ADHD J. Krause, Klaus-Henning Krause and Martin Ohlmeier 6. Quantitative and molecular genetic studies of adult ADHD P. Asherson, S. Faraone and F. Levy 7. Structural and functional MRI findings in adults with ADHD Y. Paloyelis 8. Evoked response potentials in adults with ADHD G. McLoughlin 9. Positron Emission Tomography findings in adults with ADHD M. Mehta 10. Diagnosing ADHD in adults L. Adler and David Shaw 11. Neurocognitive characteristics of adults with ADHD J. Dowson and Andrew Blackwell 12. Adult ADHD and mood disorders T. Brown 13. Adult ADHD and anxiety disorders M. Weiss 14. Adult ADHD and substance use disorders T. Wilens 15. Adult ADHD and organic brain disorders A. Niemela and H. Niederhofer 16. Autism spectrum disorders overlap ADHD in adults C. Gillberg 17. Adult ADHD and learning disorders K. Xenitidis 18. Adult ADHD and personality disorders F. van Dijk and Henrik Anckarsater 19. Psychostimulants for adult ADHD T. Spencer and J. Biederman 20. The use of non-stimulant drugs in the treatment of adult ADHD W. Verbeeck 21. Medication management in adult ADHD S. Kooij 22. Abuse potential of stimulant drugs used to treat ADHD S. H. Kollins 23. Psycho-education for adults with ADHD: impressions from the field R. Bruggeman and A. van Lammeren 24. Coaching of adults with ADHD D. Ryffel 25. Clinical applications of research on the psychosocial treatment of adult ADHD M. McDermott 26. EEG biofeedback for adult ADHD Y. Ginsberg 27. Alternative and complementary treatments for ADHD A. Arnold and S. Spetie Appendices Index.

Langwirksame Medikamente zur Behandlung der hyperkinetischen St?rungen. Teil 1: ?bersicht und Empfehlungen

Langwirksame Medikamente zur Behandlung der hyperkinetischen St?rungen. Teil 1: ?bersicht und EmpfehlungenA panel of experts from several European countries has accomplished a systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorders, on the basis of which practical recommendations for the application of these medications have been developed. The current article outlines results of this analysis, comparing the effect sizes and numbers-needed to-treat for extended-release stimulant preparations and atomoxetine (ATX). It is concluded (1) that long-acting preparations should be licensed and used. (2) However, they should not completely replace short-acting medications, in view of costs as well as the greater flexibility of dosing. Individual choices of therapy are necessary. (3) Both ATX and retarded-release stimulants should be available.Zusammenfassung: Ein Expertengremium aus mehreren europaischen Landern hat samtliche verfugbaren veroffentlichten und unveroffentlichten Studienergebnisse zum Einsatz von langwirksamen Medikamenten bei ADHS und hyperkinetischer Storung analysiert und auf dieser Grundlage Empfehlungen zur praktischen Anwendung dieser Arzneimittel entwickelt: Auf der Grundlage der Analyse wurde gefolgert: (1) Langwirksame Praparate sollten zugelassen sein und eingesetzt werden; (2) Sie sollen kurzwirksame Arzneimittel (aus Kostengrunden und wegen der hoheren Flexibilitat der Dosierung) nicht vollstandig ersetzen. Individuelle Therapieoptionen sind erforderlich. (3) Sowohl ATX als auch Stimulanzien mit retardierter Freisetzung sollten zur Verfugung stehen. Zusatzlich werden ausfuhrliche Empfehlungen gegeben, nach welchen Kriterien ein spezifisches Praparat fur den individuellen Patienten ausgewahlt werden sollte.A panel of experts from several European countries has accomplished a systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder. Based on this analysis detailed recommendations about the use of these drugs in practice have been developed: (1) Long-acting preparations should be licensed and used; (2) They should not completely replace short-acting drugs (which will be the initial treatment for many children in view of cost and the greater flexibility of dosing). Individual clinical choices are necessary. (3) Both ATX and extended-release stimulants should be available. In addition, detailed recommendations will be made with regard to the criteria to be applied in choosing a preparation for the individual patient.

Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Teil 2: Ein quantitativer Vergleich der langwirksamen Präparate

A panel of experts from several European countries has accomplished a systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorders, on the basis of which practical recommendations for the application of these medications have been developed. The current article outlines results of this analysis, comparing the effect sizes and numbers-needed to-treat for extended-release stimulant preparations and atomoxetine (ATX). It is concluded (1) that long-acting preparations should be licensed and used. (2) However, they should not completely replace short-acting medications, in view of costs as well as the greater flexibility of dosing. Individual choices of therapy are necessary. (3) Both ATX and retarded-release stimulants should be available.Langwirksame Medikamente zur Behandlung der hyperkinetischen Storungen. Teil 2: Ein quantitativer Vergleich der langwirksamen Praparate